Insider trades
Smith Julie, Director of Stoke Therapeutics STOK, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $4.7M. The latest trade was on 06/03.
Smith Julie
Director
- Company
- Stoke Therapeutics STOK
- First filing
- 23/06/02
- Trades
- 28 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- −$4.7M
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
EXEL | Open-market sale | 02/17–02/18 | 02/19 | 106,539 sh3 trades | $44.00avg. | $4,687,345.76 | −83.8% |
EXEL | Open-market sale | 25/02/27–25/02/28 | 25/02/28 | 73,808 sh2 trades | $38.00avg. | $2,804,459.1 | −87.3% |
ExelixisEXEL | Open-market sale | 24/05/21 | 24/05/23 | 27,280 sh | $21.12 | $576,153.6 | −83.4% |
